Models of Kawasaki disease

Drug Discovery Today: Disease Models

Volumn 3, Issue 1, 2006, Pages 83-89

  Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; INDOMETACIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; TOLL LIKE RECEPTOR 4;

ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIGENICITY; AUTOIMMUNITY; CANDIDA ALBICANS; CORONARY ARTERY DISEASE; DOG; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY DIAGNOSIS; LACTOBACILLUS CASEI; MOLECULAR MECHANICS; MOUSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; RABBIT; REVIEW; SWINE; SYSTEMIC VASCULITIS;

EID: 33645867962     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.03.017     Document Type: Review

References (42)

1. Burns J.C., and Glode M.P. Kawasaki syndrome. Lancet 364 (2004) 533-544
2. Falcini F. Kawasaki disease. Curr. Opin. Rheumatol. 18 (2006) 33-38
3. Matsubara T., et al. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin. Exp. Immunol. 141 (2005) 381-387
4. Newburger J.W., and Fulton D.R. Kawasaki disease. Curr. Opin. Pediatr. 16 (2004) 508-514
5. Shulman S.T., and Rowley A.H. Advances in Kawasaki disease. Eur. J. Pediatr. 163 (2004) 285-291
6. Newburger, J.W. et al. (2004) Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114, 1708-1733
7. Yeung R.S. Pathogenesis and treatment of Kawasaki's disease. Curr. Opin. Rheumatol. 17 (2005) 617-623
8. Akiyama T., and Yashiro K. Probable role of Streptococcus pyogenes in Kawasaki disease. Eur. J. Pediatr. 152 (1993) 82-92
9. Esper F., et al. Association between a novel human coronavirus and Kawasaki disease. J. Infect. Dis. 191 (2005) 499-502
10. Wang C.L., et al. Kawasaki disease: infection, immunity and genetics. Pediatr. Infect. Dis. J. 24 (2005) 998-1004
11. Benseler S.M., et al. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 116 (2005) e760-e766
12. Felsburg P.J., et al. Immunologic abnormalities in canine juvenile polyarteritis syndrome: a naturally occurring animal model of Kawasaki disease. Clin. Immunol. Immunopathol. 65 (1992) 110-118
13. Snyder P.W., et al. Pathologic features of naturally occurring juvenile polyarteritis in beagle dogs. Vet. Pathol. 32 (1995) 337-345
14. Onouchi Z., et al. Coronary artery aneurysms develop in weanling rabbits with serum sickness but not in mature rabbits. An experimental model for Kawasaki disease in humans. Angiology 46 (1995) 679-687
15. Philip S., et al. A swine model of horse serum-induced coronary vasculitis: an implication for Kawasaki disease. Pediatr. Res. 55 (2004) 211-219
16. Lehman T.J. Animal models of Kawasaki disease. Prog. Clin. Biol. Res. 250 (1987) 149-157
17. Simelyte E., et al. Bacterial cell wall-induced arthritis: chemical composition and tissue distribution of four Lactobacillus strains. Infect. Immun. 68 (2000) 3535-3540
18. Lehman T.J., et al. Variable expression of Lactobacillus casei cell wall-induced coronary arteritis: an animal model of Kawasaki's disease in selected inbred mouse strains. Clin. Immunol. Immunopathol. 48 (1988) 108-118
19. Lehman T.J., and Mahnovski V. Animal models of vasculitis. Lessons we can learn to improve our understanding of Kawasaki disease. Rheum. Dis. Clin. North Am. 14 (1988) 479-487
20. Lehman T.J. Can we prevent long term cardiac damage in Kawasaki disease? Lessons from Lactobacillus casei cell wall-induced arteritis in mice. Clin. Exp. Rheumatol. 11 Suppl. 9 (1993) S3-S6
21. Brahn E., et al. Suppression of coronary vasculitis in a murine model of Kawasaki disease using an angiogenesis inhibitor. Clin. Immunol. 90 (1999) 147-151
22. Rosenkranz M.E., et al. TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease. Circulation 112 (2005) 2966-2973
23. Duong T.T., et al. Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease. Int. Immunol. 15 (2003) 79-89
24. Chan W.C., et al. Presence of IFN-gamma does not indicate its necessity for induction of coronary arteritis in an animal model of Kawasaki disease. J. Immunol. 173 (2004) 3492-3503
25. Murata H. Experimental Candida-induced arteritis in mice. Relation to arteritis in the mucocutaneous lymph node syndrome. Microbiol. Immunol. 23 (1979) 825-831
26. Murata H., et al. The pathogenesis of experimental arteritis induced by Candida alkali-extract in mice. Jpn. J. Exp. Med. 57 (1987) 305-313
27. Ishida-Okawara A., et al. Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production. Inflammation 25 (2001) 381-387
28. Takahashi K., et al. Histopathological features of murine systemic vasculitis caused by Candida albicans extract - an animal model of Kawasaki disease. Inflamm. Res. 53 (2004) 72-77
29. Oharaseki T., et al. Susceptibility loci to coronary arteritis in animal model of Kawasaki disease induced with Candida albicans-derived substances. Microbiol. Immunol. 49 (2005) 181-189
30. Ohno N. Chemistry and biology of angiitis inducer, Candida albicans water-soluble mannoprotein-beta-glucan complex (CAWS). Microbiol. Immunol. 47 (2003) 479-490
31. Uchiyama M., et al. Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp. FEMS Immunol. Med. Microbiol. 24 (1999) 411-420
32. Kurihara K., et al. Effect of CAWS, a mannoprotein-beta-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro. Biol. Pharm. Bull. 26 (2003) 233-240
33. Kurihara K., et al. Measurement of blood clearance time by Limulus G test of Candida-water soluble polysaccharide fraction, CAWS, in mice. FEMS Immunol. Med. Microbiol. 29 (2000) 69-76
34. Nagi-Miura N., et al. Induction of coronary arteritis with administration of CAWS (Candida albicans water-soluble fraction) depending on mouse strains. Immunopharmacol. Immunotoxicol. 26 (2004) 527-543
35. Nagi-Miura, N. et al. Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction. Atherosclerosis in press, online available
36. Ohno N. Murine model of Kawasaki disease induced by mannoprotein-beta-glucan complex, CAWS, obtained from Candida albicans. Jpn. J. Infect. Dis. 57 (2004) S9-S10
37. Harada T., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) regulates cytokine induction by 1,3-beta-D-glucan SCG in DBA/2 mice in vitro. J. Interferon Cytokine Res. 24 (2004) 478-489
38. Jolles S., et al. Clinical uses of intravenous immunoglobulin. Clin. Exp. Immunol. 142 (2005) 1-11
39. Ballow M. Clinical and investigational considerations for the use of IGIV therapy. Am. J. Health Syst. Pharm. 62 (2005) S12-S18
40. Rowley A.H. Incomplete (atypical) Kawasaki disease. Pediatr. Infect. Dis. J. 21 (2002) 563-565
41. Anderson M.S., et al. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics 115 (2005) e428-e433
42. Parmar R.C., et al. Incomplete Kawasaki disease with recurrent skin peeling: a case report with the review of literature. J. Postgrad. Med. 49 (2003) 72-74